FCFS vs OPK
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCFS is a StrongBuy and OPK is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
FCFS’s FA Score shows that 1 FA rating(s) are green whileOPK’s FA Score has 0 green FA rating(s).
- FCFS’s FA Score: 1 green, 4 red.
- OPK’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
FCFS’s TA Score shows that 4 TA indicator(s) are bullish while OPK’s TA Score has 6 bullish TA indicator(s).
- FCFS’s TA Score: 4 bullish, 4 bearish.
- OPK’s TA Score: 6 bullish, 4 bearish.
Price Growth
FCFS (@Finance/Rental/Leasing) experienced а +8.65% price change this week, while OPK (@Medical Specialties) price change was -0.70% for the same time period.
The average weekly price growth across all stocks in the @Finance/Rental/Leasing industry was +4.36%. For the same industry, the average monthly price growth was -3.04%, and the average quarterly price growth was +31.60%.
The average weekly price growth across all stocks in the @Medical Specialties industry was +5.62%. For the same industry, the average monthly price growth was -3.92%, and the average quarterly price growth was -1.88%.
Reported Earning Dates
FCFS is expected to report earnings on Jul 24, 2025.
OPK is expected to report earnings on Jul 31, 2025.
Industries' Descriptions
@Finance/Rental/Leasing (+4.36% weekly)A leasing company (e.g. United Rentals, Inc. ) is typically the legal owner of the asset for the duration of the lease, while the lessee has operating control over the asset while also having some share of the economic risks and returns from the change in the valuation of the underlying asset. Per capita disposable income and corporate earnings or cash flow could be some of the critical metrics for this business – the higher the values of these metrics, the potentially greater ability of consumers/businesses to afford apartments/office spaces for rent. Other finance companies include credit/debit card payment processing companies (e.g. Visa Inc. and Mastercard), private label credit cards providers (e.g. Synchrony Financial) and automobile finance companies (e.g. Credit Acceptance Corporation).
@Medical Specialties (+5.62% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| FCFS | OPK | FCFS / OPK | |
| Capitalization | 5.75B | 920M | 625% |
| EBITDA | 907M | -65.52M | -1,384% |
| Gain YTD | 27.777 | -4.082 | -681% |
| P/E Ratio | 26.15 | 26.11 | 100% |
| Revenue | 3.15B | 863M | 365% |
| Total Cash | 127M | 95.9M | 132% |
| Total Debt | 1.92B | 327M | 588% |
FCFS | OPK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 91 | 6 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 15 | 97 | |
SMR RATING 1..100 | 60 | 91 | |
PRICE GROWTH RATING 1..100 | 40 | 61 | |
P/E GROWTH RATING 1..100 | 62 | 98 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
FCFS's Valuation (50) in the Finance Or Rental Or Leasing industry is in the same range as OPK (50) in the Biotechnology industry. This means that FCFS’s stock grew similarly to OPK’s over the last 12 months.
FCFS's Profit vs Risk Rating (15) in the Finance Or Rental Or Leasing industry is significantly better than the same rating for OPK (97) in the Biotechnology industry. This means that FCFS’s stock grew significantly faster than OPK’s over the last 12 months.
FCFS's SMR Rating (60) in the Finance Or Rental Or Leasing industry is in the same range as OPK (91) in the Biotechnology industry. This means that FCFS’s stock grew similarly to OPK’s over the last 12 months.
FCFS's Price Growth Rating (40) in the Finance Or Rental Or Leasing industry is in the same range as OPK (61) in the Biotechnology industry. This means that FCFS’s stock grew similarly to OPK’s over the last 12 months.
FCFS's P/E Growth Rating (62) in the Finance Or Rental Or Leasing industry is somewhat better than the same rating for OPK (98) in the Biotechnology industry. This means that FCFS’s stock grew somewhat faster than OPK’s over the last 12 months.
| FCFS | OPK | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 46% | 3 days ago 84% |
| Stochastic ODDS (%) | 3 days ago 56% | 3 days ago 71% |
| Momentum ODDS (%) | 3 days ago 64% | 3 days ago 76% |
| MACD ODDS (%) | 3 days ago 70% | 3 days ago 85% |
| TrendWeek ODDS (%) | 3 days ago 67% | 3 days ago 81% |
| TrendMonth ODDS (%) | 3 days ago 65% | 3 days ago 77% |
| Advances ODDS (%) | 3 days ago 64% | 5 days ago 75% |
| Declines ODDS (%) | 12 days ago 63% | 3 days ago 80% |
| BollingerBands ODDS (%) | 3 days ago 48% | 3 days ago 80% |
| Aroon ODDS (%) | 3 days ago 58% | 3 days ago 79% |
FCFS and
Correlation & Price change
A.I.dvisor indicates that over the last year, FCFS has been loosely correlated with UPBD. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if FCFS jumps, then UPBD could also see price increases.
| Ticker / NAME | Correlation To FCFS | 1D Price Change % | ||
|---|---|---|---|---|
| FCFS | 100% | +0.17% | ||
| UPBD - FCFS | 43% Loosely correlated | -0.82% | ||
| PFSI - FCFS | 40% Loosely correlated | -1.59% | ||
| EZPW - FCFS | 40% Loosely correlated | -0.37% | ||
| ENVA - FCFS | 39% Loosely correlated | -0.54% | ||
| SLM - FCFS | 37% Loosely correlated | -1.39% | ||
More | ||||